InvAscent partners with RPG Life Sciences to invest up to INR 2.43 billion in RPG Active Pharma

Bitget2026/09/21 18:14

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

InvAscent agreed to invest up to INR 2.43 billion in RPG Life Sciences’ API unit, RPG Active Pharma, in Sep 2026.
Transaction targets capacity expansion, new product development, organic growth, inorganic growth to scale a dedicated API platform.
RPG Active Pharma also agreed to buy Actis Generics, adding manufacturing footprint in Visakhapatnam.
Separate deal to acquire Raghava Life Sciences’ API business, adding an EU-GMP site near Hyderabad with about 300 KL capacity.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Invascent published the original content used to generate this news brief on September 19, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

InvAscent partners with RPG Life Sciences to invest up to INR 2.43 billion in RPG Active Pharma

You may also like

Crypto prices